Safe CNV removal is crucial for successful hESC-RPE transplantation in wet age-related macular degeneration
Stem Cell Reports · 2025
DOI: 10.1016/j.stemcr.2025.102424 ↗Kurz gefasst
Klinische Studie in der Zeitschrift Stem Cell Reports, 2025. Verfasst von Ying Xue Lv und 9 weiteren Autor:innen. Beteiligte Einrichtung: Southwest Hospital/Southwest Eye Hospital, Third Military Medical University (Army Medical University), Chongqing, China; Key Lab of Visual Damage an…. Hauptthemen laut MEDLINE: Choroidal Neovascularization, Human Embryonic Stem Cells, Retinal Pigment Epithelium, Stem Cell Transplantation. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China, Chinese Academy of Sciences.
Abstract (Originalsprache)
Subretinal transplantation of human embryonic stem cell-derived retinal pigment epithelial (hESC-RPE) cells has demonstrated therapeutic potential in macular degeneration. However, its efficiency is limited in wet age-related macular degeneration (wet AMD) due to choroidal neovascularization (CNV). To investigate the feasibility of hESC-RPE cell transplantation, we employed a surgical approach to induce retinal detachment, which allowed the removal of CNV lesions. After retinal reattachment, hESC-RPE cells were transplanted into the subretinal space. Ten patients were enrolled and divided into 2 groups. No retinal edema or CNV recurrence was observed in group 1 (7 patients without bleeding). Group 2 (3 patients with bleeding) had persistent fundus inflammation, and one patient experienced CNV recurrence. All patients were managed effectively without vision loss. These findings suggest that subretinal transplantation of hESC-RPE cells after CNV removal is safe and well tolerated; however, damage caused during CNV removal may trigger persistent inflammation and CNV recurrence. This study was registered at ClinicalTrials.gov (NCT02749734).
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Southwest Hospital/Southwest Eye Hospital, Third Military Medical University (Army Medical University), Chongqing, China; Key Lab of Visual Damage and Regeneration & Restoration of Chongqing, Chongqing, China; Jinfeng L…
- Department of Ophthalmology, the First Affiliated Hospital of Xiamen University, School of Medicine, Xiamen, Fujian Province, China.
Förderung
- National Key Research and Development Program of China
- National Natural Science Foundation of China
- Chinese Academy of Sciences
Zitieren
APA
Lv, Y. X., Li, Q. Y., Duan, P., Zhang, M. F., Liu, B., Li, S. Y., Zhao, T. T., Wang, H., Liu, Y., & Yin, Z. Q. (2025). Safe CNV removal is crucial for successful hESC-RPE transplantation in wet age-related macular degeneration. Stem Cell Reports. https://doi.org/10.1016/j.stemcr.2025.102424
Vancouver
Lv YX, Li QY, Duan P, Zhang MF, Liu B, Li SY, et al. Safe CNV removal is crucial for successful hESC-RPE transplantation in wet age-related macular degeneration. Stem Cell Reports. 2025. doi:10.1016/j.stemcr.2025.102424
BibTeX
@article{Lv2025,
author = {Lv, Ying Xue and Li, Qi You and Duan, Ping and Zhang, Min Fang and Liu, Bo and Li, Shi Ying and Zhao, Tong Tao and Wang, Hao and Liu, Yong and Yin, Zheng Qin},
title = {Safe CNV removal is crucial for successful hESC-RPE transplantation in wet age-related macular degeneration},
journal = {Stem Cell Reports},
year = {2025},
doi = {10.1016/j.stemcr.2025.102424}
}
EUVIMED